View More View Less
  • 1 Állami Népegészségügyi és Tisztiorvosi Szolgálat Országos Gyermekegészségügyi Intézet Budapest Diószegi út 64. 1113
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A Streptococcus pneumoniae fertőzések valódi jelentőségét világszerte mind a laikus, mind az általános orvosi közvélemény messze alulértékeli. Csecsemő- és kisgyermekkorban a pneumococcus otitis media a leggyakrabban antibiotikum adását igénylő kórkép, míg a lényegesen ritkább pneumococcuspleuropneumonia, szepszis, pneumococcusmeningitis még akkor is nagy kockázatú, potenciálisan halálos végű kórforma, ha nem multirezisztens a kórokozó. Életkortól függetlenül számolni kell súlyos pneumococcusfertőzéssel a krónikus betegséggel, illetve lép nélkül élőkben, a bármilyen okból immunszuppresszív terápiát igénylőkben is. Időskorúakban a leggyakoribb kórforma a pneumococcuspneumonia, amelynek halálozása az elérhető terápiás lehetőségek mellett az elmúlt évtizedekben sem csökkent számottevően. Jelenleg a pneumococcusfertőzések jelentős hányada megelőzhető lehetne aktív immunizációval. A szerző vázolja a rendelkezésre álló, 10-valens, 13-valens fehérjével konjugált és 23-valens poliszacharid pneumococcusvakcinákkal elért eddigi globális és hazai eredményeket. Ismerteti a 13-valens konjugált pneumococcusvakcina új, minden életkorra vonatkozó indikációit és a pneumococcusprevenciós programok jövőbeli kihívásait. Orv. Hetil., 2014, 155(7), 243–247.

  • http://www.who.int/nuvi/pneumococcus/en/

  • Gladstone, R. A., Jefferies, J. M., Faust, S. N., et al.: Continued control of pneumococcal disease in the UK – the impact of vaccination. J. Med. Microbiol., 2011, 60, 1–8.

    Faust S. N. , 'Continued control of pneumococcal disease in the UK – the impact of vaccination ' (2011 ) 60 J. Med. Microbiol. : 1 -8.

    • Search Google Scholar
  • Long, S. S., Pickering, L. K., Prober, C. G. (eds.): Principles and practice of pediatric infectious diseases. 3rd ed. Churchill Livingstone, New York, 2008.

    '', in Principles and practice of pediatric infectious diseases , (2008 ) -.

  • Bogaert, D., De Groot, R., Hermanns, P. W.: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis., 2004, 4, 144–154.

    Hermanns P. W. , 'Streptococcus pneumoniae colonisation: the key to pneumococcal disease ' (2004 ) 4 Lancet Infect. Dis. : 144 -154.

    • Search Google Scholar
  • Aniansson, G., Alm, B., Andersson, B., et al.: Nasopharyngeal colonization during the first year of life. J. Infect. Dis., 1992, 165 (Suppl. 1), S38–S42.

    Andersson B. , 'Nasopharyngeal colonization during the first year of life ' (1992 ) 165 J. Infect. Dis. : S38 -S42.

    • Search Google Scholar
  • http://www.ecdc.europa.eu/en/healthtopics/pneumococcal_infection/basic_facts . [Accessed: October 2011]

  • Cohen, R., Levy, C., Bingen, E., et al.: Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr. Infect. Dis. J., 2012, 31, 297–301.

    Bingen E. , 'Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media ' (2012 ) 31 Pediatr. Infect. Dis. J. : 297 -301.

    • Search Google Scholar
  • http://ecdc.europa.eu/en/publications/Publications/invasive-pneumoccocal-disease-surveillance-2010.pdf

  • Mészner, Zs., Füzi, M.: Prospective evaluation of the incidence of IPD (invasive pneumococcal disease), the serotypes and rezistance of Streptococcus pneumoniae isolates in hospitalised Hungarian children <5y. Two year observational study. In: 23rd Annual ESPID Meeting, Valencia (Spain). Book of abstracts, 2005. http://meetings.espid.org/espid2005/program/searchresults.asp

    Füzi M. , '', in 23rd Annual ESPID Meeting, Valencia (Spain). Book of abstracts , (2005 ) -.

  • Clutterbuck, E. A., Lazarus, R., Yu, L. M., et al.: Pneumococcal conjugate and plain plysaccharide vaccines have divergent effects on antigen-specific B cells. J. Infect. Dis., 2012, 205, 1408–1416.

    Yu L. M. , 'Pneumococcal conjugate and plain plysaccharide vaccines have divergent effects on antigen-specific B cells ' (2012 ) 205 J. Infect. Dis. : 1408 -1416.

    • Search Google Scholar
  • WHO: Pneumococcal vaccines. WHO position paper – 2012. Weekly Epidemiological Record, 2012, 87, 129–144. http://www.who.int/wer

    'Pneumococcal vaccines. WHO position paper – 2012 ' (2012 ) 87 Weekly Epidemiological Record : 129 -144.

    • Search Google Scholar
  • CDC: Use of 23-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep., 2013, 62, 521–524.

  • CDC: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep., 2012, 61, 816–819.

  • Blasi, F., Mantero, M., Santus, P., et al.: Understanding the burden of pneumococcal disease in adults. Clin. Microbiol. Infect., 2012, 18 (Suppl. 5), 7–14.

    Santus P. , 'Understanding the burden of pneumococcal disease in adults ' (2012 ) 18 Clin. Microbiol. Infect. : 7 -14.

    • Search Google Scholar
  • Kaplan, S. L., Barson, W. J., Lin, P. L., et al.: Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J., 2013, 32, 203–207.

    Lin P. L. , 'Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine ' (2013 ) 32 Pediatr. Infect. Dis. J. : 203 -207.

    • Search Google Scholar
  • Gruber, W. C., Scott, D. A., Emini, E. A.: Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM197 conjugate vaccine. Ann. N.Y. Acad. Sci., 2012, 1263, 15–26.

    Emini E. A. , 'Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM197 conjugate vaccine ' (2012 ) 1263 Ann. N.Y. Acad. Sci. : 15 -26.

    • Search Google Scholar
  • Miller, E., Andrews, N. J., Waight, P. A., et al.: Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine, 2011, 29, 9127–9131.

    Waight P. A. , 'Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine ' (2011 ) 29 Vaccine : 9127 -9131.

    • Search Google Scholar
  • Hortal, M., Estevan, M., Laurani, H., et al.: Hospitalized children with pneumonia in Uruguay: Pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program. Vaccine, 2012, 30, 4934–4938.

    Laurani H. , 'Hospitalized children with pneumonia in Uruguay: Pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program ' (2012 ) 30 Vaccine : 4934 -4938.

    • Search Google Scholar
  • Singleton, R., Wenger, J., Klejka, J. A., et al.: The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial. Pediatr. Infect. Dis. J., 2013, 32, 257–263.

    Klejka J. A. , 'The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial ' (2013 ) 32 Pediatr. Infect. Dis. J. : 257 -263.

    • Search Google Scholar
  • Muhammad, R. D., Oza-Frank, R., Zell, E., et al.: Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin. Infect. Dis., 2013, 56, e59–e67.

    Zell E. , 'Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children ' (2013 ) 56 Clin. Infect. Dis. : e59 -e67.

    • Search Google Scholar
  • Paradiso, P. R.: Pneumococcal conjugate vaccine for adults: A new paradigm. Clin. Infect. Dis., 2012, 55, 259–264.

    Paradiso P. R. , 'Pneumococcal conjugate vaccine for adults: A new paradigm ' (2012 ) 55 Clin. Infect. Dis. : 259 -264.

    • Search Google Scholar
  • Sanford, M.: Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) in older adults. Drugs, 2012, 72, 1243–1255.

    Sanford M. , 'Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) in older adults ' (2012 ) 72 Drugs : 1243 -1255.

    • Search Google Scholar
  • Lode, H., Ludwig, E., Kassianos, G.: Pneumococcal infection – Low awareness as a potential barrier to vaccination: Results of a European survey. Adv. Ther., 2013, 30, 387–405.

    Kassianos G. , 'Pneumococcal infection – Low awareness as a potential barrier to vaccination: Results of a European survey ' (2013 ) 30 Adv. Ther. : 387 -405.

    • Search Google Scholar
  • Tirczka, T., Berta, B.: The results of pneumococcal serotyping and rezisistance from January 1, 2008 to August 31, 2012. [A Streptococcus pneumoniae szerotipizálás és rezisztencia vizsgálat eredményei 2008.01.01-től 2012.08.31-ig.]. Mikrobiológiai körlevél, 2012, 12, 3–17. [Hungarian]

    Berta B. , 'The results of pneumococcal serotyping and rezisistance from January 1, 2008 to August 31, 2012. [A Streptococcus pneumoniae szerotipizálás és rezisztencia vizsgálat eredményei 2008.01.01-től 2012.08.31-ig.] ' (2012 ) 12 Mikrobiológiai körlevél : 3 -17.

    • Search Google Scholar
  • Tóthpál, A., Dobay, O.: Drastic changes in serotypes of carried pneumococci due to an increased vaccination rate in Hungary. [A hordozott pneumococcusok szerotípusainak drasztikus változása a megnövekedett átoltottság hatására hazánkban.] Orv. Hetil., 2012, 153, 1031–1034. [Hungarian]

    Dobay O. , 'Drastic changes in serotypes of carried pneumococci due to an increased vaccination rate in Hungary. [A hordozott pneumococcusok szerotípusainak drasztikus változása a megnövekedett átoltottság hatására hazánkban.] ' (2012 ) 153 Orv. Hetil. : 1031 -1034.

    • Search Google Scholar
  • The present state and results of the pneumococcal surveillance in Hungary, October 2012. [A pneumococcus surveillance jelenlegi helyzete és eredményei, Magyarország, 2012. október.]. Országos Epidemiológiai Központ, Epinfo, 2012, 19 (45), 521–528. [Hungarian]

  • Tóthpál, A., Laub, K., Kardos, Sz., et al.: Changes in the serotypes of Hungarian pneumococci isolated mainly from invasive infections: A review of all available data between 1988 and 2011. Acta Microbiol. Immunol. Hung., 2012, 59, 423–433.

    Kardos Sz. , 'Changes in the serotypes of Hungarian pneumococci isolated mainly from invasive infections: A review of all available data between 1988 and 2011 ' (2012 ) 59 Acta Microbiol. Immunol. Hung. : 423 -433.

    • Search Google Scholar
  • Ludwig, E., Bonanni, P., Rohde, G., et al.: The remaining challenges of pneumococcal disease in adults. Eur. Respir. Rev., 2012, 21, 57–65.

    Rohde G. , 'The remaining challenges of pneumococcal disease in adults ' (2012 ) 21 Eur. Respir. Rev. : 57 -65.

    • Search Google Scholar
  • Johnson, H. L., Deloria-Knoll, M., Levine, O. S., et al.: Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The Pneumococcal Global Serotype Project. PLoS Med., 2010, 7, e1000348.

    Levine O. S. , 'Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The Pneumococcal Global Serotype Project ' (2010 ) 7 PLoS Med. : e1000348 -.

    • Search Google Scholar